https://www.macrotrends.net/stocks/charts/CSBR/champions-oncology/net-income
Champions Oncology Net Income 2012-2026 | CSBR | MacroTrends
Champions Oncology net income from 2012 to 2026. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have...
champions oncologynet income20122026csbr
https://www.benzinga.com/quote/CSBR/short-interest
Champions Oncology Stock Short Interest Report | NASDAQ:CSBR | Benzinga
Short interest for Champions Oncology gives investors a sense of the degree to which investors are betting on the decline of Champions Oncology's stock. Short...
champions oncologyshort intereststockreportnasdaq
https://www.nasdaq.com/market-activity/stocks/csbr
Champions Oncology, Inc. Common Stock (CSBR) Stock Price, Quote, News & History | Nasdaq
Discover real-time Champions Oncology, Inc. Common Stock (CSBR) stock prices, quotes, historical data, news, and Insights for informed trading and investment...
champions oncologycommon stockprice quotenews historyinc
https://www.fxempire.com/stocks/csbr/financials/balance-sheet
Champions Oncology, Inc. (CSBR) Balance Sheet | FXEmpire
Explore Champions Oncology, Inc. (CSBR) balance sheet in detail on our platform. Access comprehensive data on assets, liabilities, equity, and more for a clear...
champions oncologybalance sheetinccsbr
https://www.macrotrends.net/stocks/charts/CSBR/champions-oncology/roi
Champions Oncology Return on Investment 2012-2026 | CSBR | MacroTrends
Current and historical return on investment (ROI) values for Champions Oncology (CSBR) over the last 10 years.
return on investmentchampions oncology20122026csbr
https://www.nasdaq.com/market-activity/stocks/csbr/news-headlines
Champions Oncology, Inc. Common Stock (CSBR) News Headlines | Nasdaq
Stay up-to-date on Champions Oncology, Inc. Common Stock (CSBR) news with the latest updates, breaking headlines, news articles, and more from around the web...
champions oncologycommon stocknews headlinesinccsbr
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/champions-oncology-reports-quarterly-revenue-of-14.0-million-890183
Champions Oncology Reports Quarterly Revenue of $14.0 Million
Annual Revenue of $50.2 Million HACKENSACK, NJ / ACCESSWIRE / July 18, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced...
champions oncology14 0reportsquarterlyrevenue
https://www.macrotrends.net/stocks/charts/CSBR/champions-oncology/dividend-yield-history
Champions Oncology - 55 Year Dividend History | CSBR | MacroTrends
Historical dividend payout and yield for Champions Oncology (CSBR) since 1971. The current TTM dividend payout for Champions Oncology (CSBR) as of May 15, 2026...
champions oncologydividend history55yearcsbr
https://www.prnewswire.com/news-releases/champions-oncology-reports-resignation-of-director-164923696.html
Champions Oncology Reports Resignation Of Director
/PRNewswire/ -- Champions Oncology, Inc. (OTC: CSBR), a company engaged in the development of advanced technology solutions and services to personalize the...
champions oncologyreportsresignationdirector
https://www.prnewswire.com/news-releases/champions-oncology-reports-fiscal-2012-second-quarter-financial-results-135610118.html
Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
/PRNewswire/ -- Champions Oncology, Inc. (OTC: CSBR) reported the following results: Fiscal Year 2012 Second Quarter Financial Results: Operating revenues...
champions oncologysecond quarterreportsfiscal2012
https://www.biospace.com/champions-oncology-reports-record-quarterly-revenue-of-14-3-million
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million - BioSpace
Dec 14, 2022 - Champions Oncology, Inc., a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic...
champions oncology14 3reportsrecordquarterly
https://www.benzinga.com/insights/earnings/24/12/42413483/a-peek-at-champions-oncologys-future-earnings
A Peek at Champions Oncology's Future Earnings - Champions Oncology (NASDAQ:CSBR) - Benzinga
at championspeekoncology
https://www.prnewswire.com/news-releases/champions-oncology-reports-results-for-the-second-quarter-ended-october-31-2015-300192650.html
Champions Oncology Reports Results for the Second Quarter Ended October 31, 2015
/PRNewswire/ -- Champions Oncology, Inc. (CSBR), engaged in the development of advanced technology solutions and services to personalize the development and...
champions oncologyfor the
https://www.biospace.com/champions-oncology-announces-the-addition-of-brady-davis-as-president
Champions Oncology Announces the Addition of Brady Davis as President - BioSpace
Oct 18, 2023 - Champions Oncology, Inc., a global preclinical and clinical research services provider that offers end-to-end oncology solutions, has appointed Brady Davis as...
champions oncologyannouncesaddition
https://www.biospace.com/champions-oncology-announces-the-launch-of-lumin-bioinformatics-its-new-oncology-data-driven-saas-program
Champions Oncology Announces the Launch of Lumin Bioinformatics, Its New Oncology Data-Driven SaaS...
Nov 17, 2020 - Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider that is transforming drug discovery through innovative...
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/champions-oncology-to-announce-third-quarter-financial-results-on-thu-1143711
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
HACKENSACK, NJ / ACCESS Newswire / March 5, 2026 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its...
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-csbr/champions-oncology/news/the-market-lifts-champions-oncology-inc-nasdaqcsbr-shares-27
The Market Lifts Champions Oncology, Inc. (NASDAQ:CSBR) Shares 27% But It Can Do More - Simply Wall...
Champions Oncology, Inc. ( NASDAQ:CSBR ) shareholders would be excited to see that the share price has had a great...
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/champions-oncology-reports-quarterly-revenue-of-14.1-million-adjusted-916210
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
HACKSENSACK, NJ / ACCESSWIRE / September 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that...
https://www.championsoncology.com/
Global Oncology CRO Services | Champions Oncology
Champions Oncology is a leading Preclinical Oncology CRO, and clinical specialty testing services provider. Let us accelerate your research.
oncology cro servicesglobalchampions